hemaPEN
Australia, New Zealand, UK, EU and USA
Advanced precision microsampling
Confident and accurate results begin with hemaPEN.
hemaPEN® is a microsampling tool that enables the collection of four volumetrically fixed, accurate and precise, samples from a single source.
Where there is no option to compromise, the hemaPEN is designed to maintain sample integrity for quantitative analysis and enable information-rich decision making.
hemaPEN is an easy to use advanced precision microsampling tool that can be used by anyone in any place.
Interested in hemaPEN and microsampling innovations?
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
hemaPEN
Contact us for more information or to request a quote
Advanced precision microsampling
hemaPEN provides a convenient sampling procedure for collection and storage of four dried blood spot (DBS) samples to drive information-rich decision making.
Unlike conventional DBS sampling tools, hemaPEN enables collection of an accurate and precise fixed micro-volume, and is designed to maintain sample integrity for quantitative analysis.
An easy-to-use sophisticated microsampling tool in the hands of non-analysts.
Features and benefits
- Pen-like design for intuitive use.
- Ability to collect blood from any source.
- Capillary-based technology enables autonomous accurate fixed volume collection.
- Four replicate samples from a single source.
- Eliminates analytically relevant hematocrit bias.
- Single-use and tamper-resistant.
- Contained sample to minimize contamination.
- Consistent sample drying profile.
- Dried format for simplified storage and logistics.
- Samples integrated directly into analytical workflow.
- Sample cartridge compatible with standard 96-/24-well plates.
- 2D barcode and individual device serial number for traceability and chain of custody.
- Space available for customized laboratory labelling.
Recommended applications
- Quantitative analysis
- Small volume sampling
- Frequent sampling
- Remote sampling
- Blood sampling
Product specifications
hemaPEN functionality remains consistent independent of substrate. Each hemaPEN is identified through a specific model number which references substrate material, volume of capillaries and hemaPEN model type.
| Substrate | Volume reference | Model | Model number |
| D* = 226™ | 300 = 2.74 μL | S = Standard (base model) | D300S |
| W† = 903® | 300 = 2.74 μL | S = Standard (base model) | W300S |
Technical data
| Product features | |
| Sample type | Whole blood |
| Storage format | Dried |
| Sample volumetric accuracy | 2.74 μL ±5% (0.14 μL) |
| Volumetric precision | CV <2.5% (interdevice) |
| Number of samples collected | 4 |
| Capillary specification | K2 EDTA-coated borosilicate Type 1 USP |
| Substrate dimensions | 3.5 mm diameter |
| Substrate | 226™ or 903® |
| Shelf life | One year |
| Material and colors | |
| Product color | White main body, a clear plastic tip and base and a green indicator stripe |
| Packaging | |
| Units/pack | Provided as a single unit per pack |
| Pack dimensions | 160 mm x 230 mm x 50 mm |
*226™ supplied by PerkinElmer Pty Ltd. 226™ is a trademark of PerkinElmer, Inc or its affiliated entities. †903® 100% cotton fiber supplied by Eastern Business Forms, Inc. 903® is a registered trademark of Eastern Business Forms, Inc.
More
More information about hemaPEN
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
Brochure - hemaPEN
Download: Brochure - hemaPEN [PDF]
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
Product Specification Sheet - hemaPEN
Download: Product Specification Sheet - hemaPEN [PDF]
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
Quick guide - hemaPEN
Download: Quick guide - hemaPEN [PDF]
Also see: Instructions for use - hemaPEN
Also see: Video - Instructional video for hemaPEN use
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
Quick guide translations - hemaPEN
Download: Quick guide translations - hemaPEN [PDF]
Languages:
- Bulgarian/български (BG)
- Croatian/Hrvatski (HR)
- Czech/čeština (CS)
- Danish/Dansk (DA)
- Dutch/Nederlands (NL)
- Estonian/Eesti keel (ET)
- French/Français (FR)
- German/Deutsch (DE)
- Greek/Ελληνικά (EL)
- Hungarian/Magyar (HU)
- Italian/Italiano (IT)
- Latvian/Latviešu valoda (LV)
- Lithuanian/Lietuvių kalba (LT)
- Norwegian/Norsk (NO)
- Polish/Polski (PL)
- Portuguese/Português (PT)
- Romanian/Română (RO)
- Slovak/Slovenčina (SK)
- Slovene/Slovenščina (SL)
- Spanish/Español (ES)
- Swedish/Svenska (SV)
Also see: Instructions for use - hemaPEN
Also see: Video - Instructional video for hemaPEN use
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
Instructions for use - hemaPEN
Download: Instructions for use - hemaPEN [PDF]
Also see: Video - Instructional video for hemaPEN use
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
Video - Instructional video for hemaPEN use
Play the video below, or view on our YouTube channel.
Also see: Instructions for use - hemaPEN
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
Product Data Sheet - hemaPEN
Download: Product Data Sheet - hemaPEN [PDF]
Also see: Part Number List - hemaPEN
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
Part Number List - hemaPEN
Download: Part Number List - hemaPEN [PDF]
Also see: Product Data Sheet - hemaPEN
Find in table:
| Part number | Part description and detail |
|---|---|
| 498100000 | hemaPEN D300S |
| 498100010 | hemaPEN W300S |
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
Brochure - SARS-CoV-2 serology testing
Post-approval efficacy surveillance
Download: Brochure - SARS-CoV-2 serology testing [PDF]
The Synexa assay kit is supplied for research purposes only. Not for therapeutic or diagnostic use.
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
